Category: Ultrasound
SonoSite Inc.'s significant gross margin boost, along with contributions from new acquisition CardioDynamics, drives a 341 percent bottom-line surge for the second quarter.
SonoSite Inc. (NSDQ:SONO) bounced to a 341 percent profit increase for the second quarter.
The Bothell, Wash.-based portable ultrasound maker reported net earnings of $1.9 million, or 12 cents per diluted share, on sales of $61.5 million during the three months ended June 30. That compares with net earnings of $425,000, or 2 cents per diluted share, on revenue of $52 million during the same period last year.
Second-quarter sales for Misonix Inc. fall 31 percent as it swings to $367,000 in Q2 red ink.
Misonix Inc. (NSDQ: MSON) posted second-quarter sales of $3.4 million for the three months ended Dec. 31, 2009, down 31 percent compared with $4.9 million during the same period in fiscal 2009. Net losses were $367,000, compared with net income of $194,000 during Q2 2009:
GE Healthcare's Vscan, a handheld ultrasound device, hits the market in the U.S., Europe, India and Canada.
GE Healthcare's handheld ultrasound device, the Vscan, hit the market in the U.S., Europe, India and Canada today.
The device, which is roughly the size of a smart phone, won 510(k) clearance from the Food & Drug Administration, CE Mark approval in the European Union and a Medical Device License from Health Canada. GE ran a study of the device's use in real-world setting before a wider release.
SonoSite Inc.'s fourth-quarter net income plunges 63 percent on flat Q4 sales of $70 million.
SonoSite Inc. (NSDQ:SONO) posted fourth-quarter sales of $69.7 million for the three months ended Dec. 31, 2009, flat compared with $70.1 million during the same period in 2008. Net income fell 63.4 percent to $2.2 million, compared with $6 million during Q4 2008:
Covidien sues Ethicon Endo-Surgery -- again -- accusing Johnson & Johnson subsidiary of violating a trio of patents with its Harmonic line of ultrasonic surgical devices
Tyco Healthcare v. Ethicon Endo-Surgery is becoming a grudge match for the ages.
Two years after a federal court judge essentially declared their long-running patent fight a tie -- siding with Ethicon by dismissing the case but also telling Tyco it was free to re-file -- Covidien plc, Tyco Healthcare's successor company, is now doing exactly that.
A new distribution pact with a Chilean medical-device seller coincides with a renewed effort by Misonix Inc. to market ultrasound surgical tools in Latin America and other foreign markets.
Misonix Inc. (NASQ:MSON) struck a deal to sell its SonaStar and BoneScalpel surgical tools in Chile.
Officials with Farmingdale, N.Y.-based Misonix said the new distribution agreement with Neuromed Chile SA coincides with a renewed focus by the ultrasound device manufacturer on the Latin American market.
"We are particularly pleased that they will be distributing two of our key products through their well established surgical products organization," Misonix Chief Executive Michael McManus said in prepared remarks.